Management of impacted proximal ureteral stone: Extracorporeal shock wave lithotripsy versus ureteroscopy with holmium: YAG laser lithotripsy

Urology Annals

Volumn 5, Issue 2, 2013, Pages 88-92

  Khalil, Mostafa ^a  

^a MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

impacted stone; laser lithotripsy; Shock wave lithotripsy

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; CONSERVATIVE TREATMENT; EXTRACORPOREAL LITHOTRIPSY; FEMALE; HEMATURIA; HOLMIUM LASER; HUMAN; INTERMETHOD COMPARISON; LASER LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; URETER STONE; URETEROLITHOTOMY; URETEROSCOPY; URINARY TRACT INFECTION;

EID: 84876888656     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.110004     Document Type: Article

References (19)

1. Coppola D, editor. Mechanisms of Oncogenesis: An Update on Tumorigenesis. 1st ed. Springer: New York; 2010. p. 279-85.
2. Iraqi Cancer Registry, 2005.
3. Rosai J. Urinary tract. In: Rosai and Ackerman's Surgical Pathology. 9th ed. Philadelphia: Elsevier; 2004. p. 1326-37.
4. Peterson OR, Sesterhenn AI, Davis JC. Urologic pathology. 3rd ed. Philadelephia: Lippincott Williams and Wilkins; 2007. p. 146-22.
5. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou J. Guidelines on TaT1 (non-muscle invasive) bladder Cancer. European Association of Urology (EAU): Arnhem, The Netherlands; 2009.
6. Matalka I, Bani-Hani K, Shotar A, Bani Hani O, Bani-Hani I. Transitional cell carcinoma of the urinary bladder: A clinicopathological study. Singapore Med J 2008;49:790-4.
7. Kumar V, Abbas AK, Fausto N, editor. 8th ed. Pathologic Basis of Disease. Elsevier: Philadelephia; 2010. p. 976-80.
8. Chuang CK, Liao SK. Evaluation of CA19-9 as a tumor marker in urothelial malignancy. Scand J Urol Nephrol 2004;38:359-65.
9. Langkilde NC, Wolf H, Meldgård P, Orntoft TF. Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients. Br J Cancer 1991;63:583-6.
10. Magnani JL. The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Arch Biochem Biophys 2004;426:122-31.
11. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993;53:354-61.
12. Bahadir B, Behzatoglu K, Bektas S, Bozkurt ER, Ozdamar SO. CD10 expression in urothelial carcinoma of the bladder. Diagn Pathol 2009;4:38.
13. Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K. Stromal expression of CD10 in invasive breast carcinoma: A new predictor of clinical outcome. Virchows Arch 2002;440:589-93.
14. Afrem G, Crǎ;iţoiu S, Mǎ;rgǎ;ritescu C, Mogoantǎ; SS. The study of p53 and CA19-9 prognostic molecular markers in colorectal carcinomas. Rom J Morphol Embryol 2010;51:473-81.
15. Kajiwara H, Yasuda M, Kumaki N, Shibayama T, Osamura Y. Expression of carbohydrate antigens (SSEA- 1, sialyl-Lewis X, DU-PAN- 2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder. Tokai J Exp Clin Med 2005;30:177-82.
16. Kandemir NO, Bahadir B, Gun BD, Yurdakan G, Karadayi N, Özdamar ŞO. CD10 expression in urothelial bladder carcinomas: Staining patterns and relationship with pathologic parameters. Turk J Med Sci 2010;40:177-84.
17. Murali R, Delprado W. CD10 immunohistochemical staining in urothelial neoplasms. Am J Clin Pathol 2005;124:371-9.
18. Abdou AG. CD10 expression in tumour and stromal cells of bladder carcinoma: An association with bilharziasis. APMIS 2007;115:1206-18.
19. Bostrom PJ, van Rhijn B, Fleshner N, Finelli A, Jewett M, Thoms John, et al. Staging and staging errors in bladder cancer. European Urology Supplements 2010;9:2-9.